Pfizer
PFEPfizer is a global research-based biopharmaceutical company engaged in the discovery, development, manufacture, and commercialization of medicines and vaccines.
Earnings
Next report
Nov 3, 2026 (in 2 months)Financials
Q2 2026Income statement
Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
Profile
Pfizer is a global research-based biopharmaceutical company engaged in the discovery, development, manufacture, and commercialization of medicines and vaccines. The company focuses on delivering innovative treatments across various therapeutic areas, including oncology, immunology, and infectious diseases, while navigating highly regulated global markets. Its core value proposition centers on leveraging large-scale R&D investment to address significant unmet medical needs and maintaining a differentiated product pipeline.
A leading global biopharmaceutical innovator that competes on the basis of efficacy, safety, and the ability to maintain market exclusivity through robust intellectual property protection.
FAQ
- What is Pfizer's market cap?
- Pfizer (PFE) has a market capitalization of $161.30B and trades on NYSE.
- What is Pfizer's revenue and profitability?
- Pfizer generated $63.7B in trailing twelve-month revenue with net income of $8.9B, representing a net margin of 15.7%. Gross margin stands at 73.2%. These figures are based on the Q2 2026 filing.
- Who are Pfizer's competitors?
- Pfizer's key competitors include Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., and others. These companies compete in similar markets and product categories.
- Who does Pfizer partner with?
- Pfizer's notable partners include World Health Organization.
- Where is Pfizer headquartered?
- Pfizer is headquartered in United States of America and employs approximately 88,000 people. It has been publicly traded since 1951.
